IL326029A - טיפול בסרטן ריאות שאינו תאים קטנים עם אלקטיניב - Google Patents

טיפול בסרטן ריאות שאינו תאים קטנים עם אלקטיניב

Info

Publication number
IL326029A
IL326029A IL326029A IL32602926A IL326029A IL 326029 A IL326029 A IL 326029A IL 326029 A IL326029 A IL 326029A IL 32602926 A IL32602926 A IL 32602926A IL 326029 A IL326029 A IL 326029A
Authority
IL
Israel
Prior art keywords
alectinib
treatment
lung cancer
small cell
cell lung
Prior art date
Application number
IL326029A
Other languages
English (en)
Inventor
Venice Rosalie Archer
Walter Bordogna
Gavaldon Andres Cardona
Sophie Maude Alice Golding
?Pouse Hilton Magalie Maudire
Johannes Alexander NO?
Lohmann Tania Helena Ochi
Thorsten Ruf
Tingting Xu
Ali Zeaiter
Original Assignee
Hoffmann La Roche
Venice Rosalie Archer
Walter Bordogna
Gavaldon Andres Cardona
Sophie Maude Alice Golding
?Pouse Hilton Magalie Maudire
Johannes Alexander NO?
Lohmann Tania Helena Ochi
Thorsten Ruf
Tingting Xu
Ali Zeaiter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Venice Rosalie Archer, Walter Bordogna, Gavaldon Andres Cardona, Sophie Maude Alice Golding, ?Pouse Hilton Magalie Maudire, Johannes Alexander NO?, Lohmann Tania Helena Ochi, Thorsten Ruf, Tingting Xu, Ali Zeaiter filed Critical Hoffmann La Roche
Publication of IL326029A publication Critical patent/IL326029A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL326029A 2023-08-31 2024-08-28 טיפול בסרטן ריאות שאינו תאים קטנים עם אלקטיניב IL326029A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP23194748 2023-08-31
EP23200990 2023-09-29
PCT/EP2024/073974 WO2025045901A1 (en) 2023-08-31 2024-08-28 Treatment of non small cell lung cancer with alectinib

Publications (1)

Publication Number Publication Date
IL326029A true IL326029A (he) 2026-03-01

Family

ID=92583356

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326029A IL326029A (he) 2023-08-31 2024-08-28 טיפול בסרטן ריאות שאינו תאים קטנים עם אלקטיניב

Country Status (8)

Country Link
EP (1) EP4770646A1 (he)
KR (1) KR20260056240A (he)
CN (1) CN121752277A (he)
AU (1) AU2024332707A1 (he)
IL (1) IL326029A (he)
MX (1) MX2026002326A (he)
TW (1) TW202513075A (he)
WO (1) WO2025045901A1 (he)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2668775T3 (es) 2009-06-10 2018-05-22 Chugai Seiyaku Kabushiki Kaisha Compuestos tetracíclicos
EP2606886B1 (en) 2010-08-20 2020-01-08 Chugai Seiyaku Kabushiki Kaisha Composition comprising tetracyclic compound
RU2016146119A (ru) 2014-04-25 2018-05-29 Чугаи Сейяку Кабусики Кайся Новый кристалл тетрациклического соединения
WO2015163448A1 (ja) 2014-04-25 2015-10-29 中外製薬株式会社 ４環性化合物を高用量含有する製剤
TWI718102B (zh) 2014-08-08 2021-02-11 日商中外製藥股份有限公司 ４環性化合物的非晶質體

Also Published As

Publication number Publication date
MX2026002326A (es) 2026-04-01
KR20260056240A (ko) 2026-04-24
WO2025045901A1 (en) 2025-03-06
AU2024332707A1 (en) 2026-02-19
EP4770646A1 (en) 2026-07-08
CN121752277A (zh) 2026-03-27
TW202513075A (zh) 2025-04-01

Similar Documents

Publication Publication Date Title
SG11202007414XA (en) Osimertinib for use in the treatment of non-small cell lung cancer
IL315441A (he) שיטות לטיפול בסרטן הריאה של תאים קטנים
EP4281063A4 (en) OXABICYCLOHEPTANE FOR THE TREATMENT OF SMALL CELL LUNG CANCER
ZA202107342B (en) Chiauranib for treatment of small cell lung cancer
SG11202013190YA (en) Combination therapy with targeted tgf-b inhibition for treatment of advanced non-small cell lung cancer
IL326946A (he) שיטות לטיפול בסרטן ריאות עם תאים שאינם קטנים
CA3303178A1 (en) Treatment of non small cell lung cancer with alectinib
IL316057A (he) טיפול משולב בסרטן ריאות בתאים קטנים
IL314687A (he) טיפול בסרטן
GB202218395D0 (en) Cancer therapy
CA3288585A1 (en) Treatment of non-small cell lung cancer
HK40119480A (en) Methods of treating small cell lung cancer
HK40116955A (en) Combination therapy for use in treatment of non-small cell lung cancer
CA3243096A1 (en) POLYTHERAPY INTENDED FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
CA3305927A1 (en) Use of an immunoconjugate for the treatment of non-small cell lung cancer
GB202308906D0 (en) Treatment of trbc1-positive T cell malignancies
IL326758A (he) טיפול בסרטן מוצק עם לזופוקסיפן
HK40080627A (en) Methods of treating small cell lung cancer with lurbinectedin formulations
IL316821A (he) טיפול בסרטן עם nuc-7738
IL320448A (he) שיטות לטיפול בסרטן באמצעות סוטורסיב
GB202311976D0 (en) Treatment of cancer
GB202218181D0 (en) Treatment of cancer
CA3303567A1 (en) Methods of treating non-small cell lung cancer
CA3302440A1 (en) Treatment of solid cancer with lasofoxifene
GB202201803D0 (en) Treatment of Cancer